Publications

Zanier E.R., Pischiutta F., Rulli E. et al. MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trial. ICMx 11, 56 (2023). OPEN ACCESS

https://doi.org/10.1186/s40635-023-00535-1 

Magatti, M., Pischiutta, F., Ortolano, F. et al. Systemic immune response in young and elderly patients after traumatic brain injury. Immun Ageing 20, 41 (2023). OPEN ACCESS

https://doi.org/10.1186/s12979-023-00369-1 

Pischiutta F., Cavaleiro H., Caruso E. et al. A novel organotypic cortical slice culture model for traumatic brain injury: molecular changes induced by injury and mesenchymal stromal cell secretome treatment.  Front Cell Neurosci. 17:1217987 (2023). OPEN ACCESS

https://doi.org/10.3389/fncel.2023.1217987 

Moro F., Lisi I., Tolomeo D. et al. Acute Blood Levels of Neurofilament Light Indicate One-Year White Matter Pathology and Functional Impairment in Repetitive Mild Traumatic Brain Injured Mice. J Neurotrauma 40(11-12):1144-1163 (2023).

https://doi.org/10.1089/neu.2022.0252 

Pischiutta F., Cavaleiro H., Caruso E. et al. Mesenchymal stromal cell secretome for traumatic brain injury: Focus on immunomodulatory action. Exp Neurol. 357:114199 (2022). OPEN ACCESS

https://doi.org/10.1016/j.expneurol.2022.114199 

Pischiutta F., Caruso E., Lugo A. et al. Systematic review and meta-analysis of preclinical studies testing mesenchymal stromal cells for traumatic brain injury. NPJ Regen Med. 6(1):71 (2021).  OPEN ACCESS

https://doi.org/10.1038/s41536-021-00182-8 

Carbonara M., Fossi F., Zoerle T. et al. Neuroprotection in Traumatic Brain Injury: Mesenchymal Stromal Cells can Potentially Overcome Some Limitations of Previous Clinical Trials. Front Neurol. 9:885. OPEN ACCESS

https://doi.org/10.3389/fneur.2018.00885